EGFR and cancer: TKIs, structurally diverse, selectively target specific tyrosine kinase receptors such as epidermal growth factor receptor (EGFR),[13] vascular endothelial growth factor receptor (VEGFR),[14] and platelet-derived growth factor receptor.[15] This specificity allows tailored therapeutic interventions based on the molecular profile of the targeted cancer.